Novavax
NVAX
$8.94
+6.18%
Related headlines
NVAX price trend
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Novavax's 12-month outlook, with a consensus price target around $14.00 and implied upside of +56.6% versus the current price.
Average Target
$14.00
0 analysts
Implied Upside
+56.6%
vs. current price
Analyst Count
—
covering this stock
Price Range
$7 - $25
Analyst target range
NVAX Technical Analysis
Beta
2.42
2.42x market volatility
Max Drawdown
-35.9%
Largest decline past year
52-Week Range
$6-$12
Price range past year
Annual Return
+17.2%
Cumulative gain past year
| Period | NVAX Return | S&P 500 |
|---|---|---|
| 1m | +13.0% | +2.5% |
| 3m | -2.9% | +2.7% |
| 6m | -2.8% | +11.1% |
| 1y | +17.2% | +20.5% |
| ytd | +25.4% | +12.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
Valuation Analysis: Is NVAX Overvalued?
PE
2.5x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
2.2x
Enterprise Value Multiple